Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC

Fig. 4

Expression analysis, survival analysis and ROC analysis of the 5 key genes between non-cirrhotic HCC and corresponding normal tissues. a CCL19 expression between non-cirrhotic HCC and normal tissues in TCGA; b CCL25 expression between non-cirrhotic HCC and normal tissues in TCGA; c CNR1 expression between non-cirrhotic HCC and normal tissues in TCGA; d CNR1 expression between cirrhotic HCC and normal tissues in TCGA; e PF4 expression between cirrhotic HCC and normal tissues in TCGA; f PPBP expression between cirrhotic HCC and normal tissues in TCGA; g CNR1 survival analysis in cirrhotic HCC; h CCL19 ROC analysis in non-cirrhotic HCC; i CCL25 ROC analysis in non-cirrhotic HCC; g CNR1 ROC analysis in non-cirrhotic HCC; k CNR1 ROC analysis in cirrhotic HCC; l PF4 ROC analysis in cirrhotic HCC; m PPBP ROC analysis in cirrhotic HCC

Back to article page